Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMBLE perioperative and recovery intravenous iron trial in anaemic major surgery patients
ACTRN12622001447741Phase 4Terminated
- Sponsor
- South Metropolitan Health Service
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Ferric carboxymaltose with Placebo (2 arms). Primary endpoint: Change in haemoglobin concentration. Started Feb 2023; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12622001447741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001447741.